CLDN7 and neoplasm: Significantly, loss of claudin-7 expression was associated with the high pathologic grade (P=0.027), advanced TNM staging (P=0.00), large tumor size (P=0.01), the presence of microscopic peri-neural (P=0.01) and vascular (P=0.031) invasions and regional lymph node involvement (P=0.001).